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Abstract 
Coadministration of pomegranate rind extract (PRE) and zinc (II) ions has recently 
been reported as a potential new topical treatment for Herpes simplex virus (HSV) 
infections. In the current work we examined the in vitro topical delivery of 
punicalagin (major phytochemical of PRE) and zinc from hydrogels across epithelial 
membranes that can become infected with HSV.  
Porcine epidermal, buccal and vaginal mucous membranes were excised and mounted 
in Franz diffusion cells and dosed with a simple hydrogel containing PRE and zinc 
sulphate (ZnSO4). The permeation of punicalagin and zinc were determined by HPLC 
and ICPMS respectively; punicalagin was also determined in the basal layers by 
reverse tape stripping. Receptor phases from the epidermal membrane experiment 
were also used to challenge HSV-1 in Vero host cells, and ex vivo porcine skin was 
used to probe COX-2 modulation. 
Punicalagin and zinc permeated each of the three test membranes, with significantly 
greater amounts of both delivered across the epidermal membrane. The amounts of 
punicalagin permeating the buccal and vaginal membranes were similar, although the 
amount of zinc permeating the vaginal membrane was comparatively very large – it is 
known that zinc interacts with vaginal mucosa. The punicalagin recovered by reverse 
tape stripping of the epidermal, buccal and vaginal membranes gave 0.47 ± 0.016, 
0.45 ± 0.052 and 0.51 ± 0.048 nM cm-2 respectively, and were statistically the same 
(p<0.05). A 2.5 log reduction was achieved against HSV-1 using diffusion cell 
receptor phase, and COX-2 expression was reduced by 64% in ex vivo skin after 6h.   
Overall, a hydrogel containing 1.25 mg mL-1 PRE and 0.25 M ZnSO4 was able to 
topically deliver both the major bioactive compound within PRE and Zn (II) across all 
membranes and into the site specific region of Herpes simplex vesicular clusters, 
while maintaining potentiated virucidal and anti-inflammatory properties. This novel 
therapeutic system therefore has potential for the topical treatment of HSV infections. 
Key words:  Punica granatum L., pomegranate rind extract, punicalagin, zinc, 
virucidal, anti-inflammatory, drug delivery, Herpes simplex virus, skin, buccal cavity, 
vagina, reverse tape stripping. 
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1. Introduction 
 The pomegranate, fruit of the Punica granatum L tree, has been venerated 
since ancient times for its benefits to health (Jurenka, 2008). In recent years 
pomegranates have been studied more rigorously, partly in response to public 
preference to medicines of natural origin. The major class of phytochemicals in the 
pomegranate is the polyphenols and accounts for much of their antioxidant activity, 
flavour and colour. Extracts from the rind of the pomegranate have a large number of 
these polyphenols e.g. flavonoids, anthocyanins such as delphinidin, cyanidin and 
proanthocyanidins. Of particular interest are the hydrolysable tannins: punicalagin,  
punicalin, pedunicalin, as well as gallic and ellagic acid esters of glucose (Mustafa et 
al. 2009). The remaining phytochemicals present are organic and phenolic acids, 
sterols and triterpenoids, fatty acids, triglycerides, and saccharides (Seeram et al. 
2005). Punicalagin, a large polyphenolic compound with a molecular mass of 1084.7, 
constitutes 80-85% w/w of total pomegranate tannins. Punicalagin and its degradation 
compounds are thought to be the main bioactive extracts present in PRE and (Seeram 
et al. 2005). Other bioactivities have been described for PRE and punicalagin, 
including antiproliferation, apoptopic and antimicrobial properties (Seeram et al. 
2005; Negi and Jayaprakasha, 2003; Howell and D'Souza 2013). 
Pomegranate extracts have shown antiviral effects against norovirus (Su et al. 
2010), influenza virus (Haidari et al. 2009), HIV-1 (Neurath et al 2005) and 
poxviruses (Konowalchuk and Speirs, 1976) and it has been postulated that the 
interaction of plant polyphenolic compounds with the viral capsid protein may cause 
irreversible damage or reversible blocking of certain regions/areas of the capsid 
protein (Li et al. 2012). The phytochemicals of the pomegranate are concentrated in 
the pericarp and thus the pharmacological activity of PRE has been examined (Al-
Zoreky, 2009). The combination of PRE and FeSO4 was reported to produce an 
eleven-log reduction in the plaque forming ability of Pseudomonas aeruginosa and 
Escherichia coli phages within two minutes of application of an aqueous mixture at 
room temperature (Stewart et al. 1998). More recently, we have demonstrated that the 
combination of PRE and ZnSO4 has potent virucidal activity against Herpes simplex 
virus-1 (HSV-1), Herpes simplex virus-2 (HSV-2) and aciclovir-resistant HSV-1 
(Houston, 2011; Houston et al, submitted not yet accepted, a) where up to 6-log 
reduction was attributed to the potentiation of punicalagin, in a mechanism that is 
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currently under investigation. Furthermore, it was also found that PRE downregulates 
the short-lived endogenous inflammatory enzyme COX-2 when applied topically to 
ex vivo skin (Houston et al, submitted not yet accepted, b), which supports other 
reports of anti-inflammatory activity of PRE (Colombo et al. 2013). Together, these 
attributes indicate that coadministered PRE and zinc (II) has potential in a range of 
topical herpetic disorders.  
HSV types 1 and 2 commonly infect skin and mucosal membranes. As there is 
currently no cure, individuals infected with HSV will harbour latent virus in regional 
nerve ganglia for the remainder of their lives. Symptoms of primary herpes include 
fever, malaise, tender lymphadenopathy of the head and neck, and vesicles and ulcers 
anywhere on oral mucosa, the pharynx, lips and perioral skin. The gingiva is typically 
enlarged and erythematous and lesions are painful, making it difficult to eat and drink. 
An important consideration for drug therapy is that the earlier the treatment is 
initiated, the better the outcome, especially for antiviral drugs; however, the lesions 
usually resolve within 10-14 days even without drug intervention. The HSV virus, 
which is always present in the body, tends to overcome the immune system and erupt 
as fluid-filled blisters that turn into sores when immune defences are run down - this 
is especially common during a cold viral infection. Recurring herpes has vesicles and 
ulcers occurring on keratinized mucosal surfaces and the lesions are grouped in a tight 
cluster - often a sudden prodrome of pain, tingling, or numbness precedes the onset of 
lesions.  The frequency of recurrence varies with the individual (Pringle, 2016). 
Genital herpes generally causes mild symptoms; it is also possible to be infected and 
have no symptoms, so not everyone who is infected may be aware of the infection. 
When symptoms are present, they consist of typically painful blisters around the 
genital or rectal area. The blisters break open, form ulcers, and take 2 to 4 weeks to 
heal. With the first outbreak of genital herpes, a person may also experience flu-like 
symptoms including fever, body aches, and swollen lymph nodes. Immediately prior 
to an outbreak, there may be an itching, burning, or tingling sensation of the skin. In 
women, genital herpes usually causes blistering lesions on the vulva and around the 
vaginal opening that progress to ulcer formation. The infection spreads to involve the 
cervix in most cases, leading to cervicitis (inflammation of the cervix). In some cases 
cervicitis may be the only sign of genital herpes infection. Infection and inflammation 
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of the urethra accompanies the infection in some women, leading to pain on urination. 
After the initial infection, a person may or may not have outbreaks later in life. 
The current work thus investigated the in vitro topical delivery of PRE and 
ZnSO4 and its breadth of applicability to the various anatomical regions prone to 
infection with HSV-1 and HSV-2. Herpes simplex labialis lesions (cold sores) mainly 
affect the perioral region (in which case normal skin can be used as a model for 
determining penetration), however, they also occur on the lips and in the mucous 
membranes of the buccal cavity, such as inner cheeks and gums (Pringle, 2016).  
Anogenital infections of HSV can involve the areas of normal skin or mucous 
membranes, or both. Depending on the progression of the lesion, the precise location 
of the viral load can vary from within the skin to near or on the surface (Salameh et al. 
2012). Here, we used porcine skin, buccal and vaginal membranes excised by blunt 
dissection which, being intact, would represent the minimum amounts of permeants 
delivered into these membranes. In the case of advanced lesions the skin barrier 
would compromised and so the amounts deliverable would be expected to be 
substantially greater, particularly given the hydrophilic nature of the actives and the 
hydrated state of the buccal and vaginal mucosal membranes. 
The objective of this work was thus to determine the in vitro or ex vivo 
permeation of punicalagin and zinc (II) using models for HSV-1 and HSV-2 vesicular 
specific sites, from topically applied hydrogel formulations containing PRE and 
ZnSO4 and to determine if virucidal and anti-inflammatory activities are retained 
following membrane permeation.  
 
2. Materials and methods 
2.1. Materials 
 Pomegranates were obtained from a local supermarket and were of Spanish 
origin. Hydroxypropylmethyl cellulose (Methocel 856N) was a gift from The Dow 
Chemical Company, MI, USA. Zinc sulphate (ZnSO4), Dulbecco's modified eagle 
medium (DMEM), potassium hydrogen phthalate, bovine serum albumen (BSA), 
bromophenol blue (99%, UV-VIS), dimethyl sulfoxide (DMSO, 99%), gentamycin 
sulfate, glycerol (99%), glycine (99%), N,N,N',N'-tetramethyl-ethylenediamine 
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(TEMED, 99%), positive control lysate for COX-2 (Human cells-13 lysate, 250 μg in 
0.1 mL), sodium bicarbonate (NaHCO3, 99%), sodium chloride (NaCl, 99.9%), 
sodium dodecyl sulphate (SDS), tris (hydroxymethyl)methylamine (Tris base, 
99.8%), Thermo Scientific SuperSignal® west dura extended duration substrate, filter 
paper QL100 (equivalent to Whatman Grade 1), nitrocellulose transfer membrane 
(Whatman Protran® BA85 with pore size of 0.45 μm), trifluoroacetic acid (TFA) and 
all other solvents were of analytical grade or equivalent were obtained from Fisher 
Scientific (Loughborough, UK). Aprotinin (≥98%), dithiothreitol (DTT, 1 M in 
water), ethylene diamine tetraacetic acid (EDTA, 98%), Hanks’ balanced salt buffer 
(HBSB), leupeptin hydrochloride (≥70%), monoclonal anti-β-actin antibody produced 
in mouse (clone AC-74, ascites fluid, A 5316), [4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid] (HEPES, ≥99.5%), phenylmethylsulphonyl fluoride 
(PMSF, ≥99%), phosphate buffer solution (PBS, pH 7.4), polyoxyethylene-sorbitan 
monolaurate (Tween® 20), ponceau S, RIPA buffer and punicalagin were all 
purchased from Sigma-Aldrich (Poole, UK).  Cyclooxygenase-2 antibody (COX-2, 
#4842), anti-rabbit immunoglobulins (IgG) horseradish-peroxidase (HRP)-linked 
antibodies and positive controls for COX-2 (RAW 264.7 cells lysate, untreated or 
LPS treated) by Cell Signaling Technology were purchased from New England 
BioLabs Ltd. (Hitchin, UK). MXB autoradiography film (blue sensitive: 18 × 24 cm²) 
was obtained from Genetic Research Instrumentation (Braintree, UK). Full range 
Rainbow® recombinant protein molecular weight marker (12 - 225 kDa) was 
purchased from GE Healthcare Life Sciences (Little Chalfont, UK) and Bio-Rad 
protein assay reagent from Bio-Rad Laboratories GmbH (Munich, Germany). Freshly 
excised porcine ears, cheeks and vaginas were obtained from a local abattoir and 
immersed in iced HBSB solution upon excision, and used within 1 h of slaughtering. 
 
2.2. Preparation of Pomegranate Rind Extract (PRE) 
 Six fresh pomegranates were peeled; the rinds cut into thin strips 
approximately 2 cm in length, blended in deionised H2O (25% w/v) and boiled for 
approximately 10 min. The crude suspension was then transferred into centrifuge 
tubes and centrifuged at 10,400g 
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membrane filter. The solution was then freeze-dried, occluded from light and stored at 
- ion of each extract was analysed, 
and consisted of 20% w/w of PRE. The PRE was reconstituted by adding 2 mg to 10 
mL of pH 4.5 phthalate buffer. The solution was sonicated for 10 min at 50-60 Hz and 
-FG syringe driven filter 
unit and stored at -20°C until further use. 
 
2.3. Hydroxypropyl Methylcellulose (HPMC) Hydrogel 
 Using the ‘hot/cold’ technique, 2.5g HPMC (Methocel 856N) was added to 40 
mL pH 4.5 phthalate buffer at 80 °C with constant stirring until all particles are 
thoroughly wetted. 60 mL cold or iced deionised H2O was then added to the solution 
with constant agitation for 30 min. This enabled the hydration of the powder and the 
increase in the viscosity of the resulting hydrogel, which was then cooled to 4°C. PRE 
and ZnSO4 were added to 60 ml of cold phthalate buffer: hydrogel H1 0.5 mg mL-1 
PRE, 0.1 M ZnSO4; H2 1.25 mg mL-1 PRE, 0.25 M ZnSO4; blank contained neither 
PRE nor ZnSO4 (Table 1). Agitation of the hydrogel continued for 30 min after the 
addition of the cooled water to guarantee a uniform and evenly dispersed hydrogel. 
All formulations were refrigerated for a minimum of four hours after agitation so that 
a uniform hydrogel was formed (Dodov et al. 2005). It had previously been found that 
HPMC yielded gels with good tactile and rheological properties (Houston, 2011). 
 
2.4. Preparation of Porcine Membranes 
 Heat separated epidermis was used to model drug delivery to HSV-1 and -2 
vesicular clusters which form in the early stages of a HSV or cold sore lesion 
formation, where the skin and barrier function are still essentially intact, and could 
also represent surrounding non-labial regions either of the mouth or vagina. 
 The freshly excised porcine ears were gently washed under cool running water 
and full thickness skin was removed from the dorsal cartilage by blunt dissection, 
using a scalpel. The skin was further sectioned into 2 cm2 squares and immersed in 
water at 55°C for 1 min (Kligman and Christophers, 1963) then used straight away. 
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For the COX-2 determinations (Section 2.10), ex vivo full thickness skin was 
carefully liberated from cleaned, shaved ears, whilst being bathed continually with 
HBSB (Houston et al. submitted not yet accepted, b).  
 Heat separated buccal membrane was used as HSV-1 and -2 most commonly 
transverse the trigeminal nerve which enables the virus to present not only on the 
prolabium but also within the buccal cavity, it was important to determine the 
delivery of both punicalagin and zinc across the buccal mucosa. Porcine cheeks were 
collected from a local abattoir as soon as possible after slaughter, then transported to 
the lab immersed in iced buffered HBSB and application of test materials began 
within an hour of excision. The buccal membrane was carefully excised from the 
underlying tissues using a scalpel until only the top mucosal membrane remained, this 
was sectioned into 2 cm2 pieces and immersed in water at 55°C for 1 min, then used 
immediately. 
 Porcine vaginal membrane was used to model the presentation of HSV-1 and -
2 vesicular clusters within and around the vaginal cavity soft tissue in female Herpes 
simplex infection. Porcine vaginas were collected from a local abattoir as soon as 
possible after slaughter, then transported to the lab immersed in iced buffered HBSB 
and application of test materials began within an hour of excision. Excess fat and 
muscle was cut away from the porcine inner vaginal wall via scalpel dissection. The 
vaginal cavity was opened by cutting one vaginal wall from the vaginal opening to the 
cervix. The vaginal mucosal membrane was then trimmed using a scalpel until only 
the mucosal membrane remained, this was sectioned into 2 cm2 pieces and used 
immediately. 
 
2.5. In Vitro Membrane Permeation Determination 
 All-glass Franz diffusion cells (FDC) were used with nominal diffusional area 
of 1 cm diameter (0.88 cm2) and nominal receptor phase volume of 3 mL. The 
relevant membrane was mounted epithelium-uppermost on the lightly pre-greased 
flanges of the receptor. The donor chamber was placed on top of the membrane and 
clamped into position. A micro-stirrer bar was added to the receptor compartment, 
filled with deionised H2O and the sampling arm capped. The cells were placed on a 
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multiple stirrer plate in a thermostatically controlled water bath set at 37°C for 15 min 
to allow the temperature to reach equilibrium. An infinite dose of 300 mg aliquot of 
hydrogel H1, H2 and blank was applied (without stirring due to the fragility of the 
buccal and vaginal membranes), thus allowing determination of maximal levels of 
drug delivery. At specific timepoints the receptor fluids were removed using a sterile 
pipette and stored in 10 mL glass vials until further use; the receptor chamber was 
then refilled with deionised H2O. 
 
2.6. Reverse Tape Stripping 
 Tape stripping is typically performed to determine depth profiles for drug 
penetration into biological membranes, mainly (Williams, 2003). Here we took a 
different approach in the knowledge that replicating HSV infects the viable epidermis, 
thus the amount of permeant localised within the basal layer is of particular interest. 
Thus instead of stripping the outer layer of the membrane, which is in contact with the 
donor phase, the inner side (which is in contact with the receptor fluid) was the 
starting point of the stripping procedure. 
 The membrane was removed from the FDC after 24 h using forceps and 
dabbed clean of formulation carefully and trimmed to the area of application. A drop 
of cyanoacrylate adhesive was applied to a ceramic tile, the membrane was placed on 
the adhesive, donor phase side downwards. Regular adhesive tape strips (Sellotape) 
were then gently pressed onto the membrane and the tape was then carefully removed 
using forceps, placed in an Eppendorf vial containing 2 mL of methanol and rocked 
overnight. The tape was removed from the vial and the methanol evaporated under 
vacuum before 2 mL of deionised H2O was added. To allow a comparative 
determination of the levels of actives in the basal layer areas of the 3 test membranes, 
reverse tape stripping was conducted after 24 h.  
 
2.7. Analysis of Punicalagin by HPLC 
 In this work punicalagin was used as marker for PRE – punicalagin is the 
tannin in highest concentration in PRE and has previously been shown to exert the 
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greatest effect on Herpes simplex virus (Houston, 2011; Houston et al, unpublished a). 
The analysis was performed using an Agilent series 1100 HPLC system fitted with a 
Phenomenex Gemini NX C18 110A 250 x 2.6 mm column. Gradient elution was 
used, involving A = methanol with 0.1% trifluoroacetic acid (TFA) and B = deionised 
H2O with 0.1% TFA: 0 min A 5% B 95%, 15 min A 20% B 80%, 30 min A 60% B 
40%, 40 min A 60% B 40%. Injection volume was 20 L and detection was by UV at 
258nm. Punicalagin naturally occurs as a pair of isomers (anomers), α and β, in the 
ratio of 1:2 (Figure 1). Aqueous solutions of punicalagin standard were analysed over 
a range of concentrations and the resulting calibration curves of the α and β anomers 
(Figure 1) were used to determine total punicalagin levels by summation of the areas 
of the two corresponding peaks in the test sample chromatograms. 
 
2.8. Analysis of Zinc by Inductively Coupled Plasma Mass Spectrometry (ICPMS) 
 The levels of zinc permeating the skin were determined by ICPMS analysis 
(Li et al. 2012) using a Thermo Elemental X Series 2 ICP-MS system equipped with a 
Plasma Screen.  Analysis was performed using 66Zn as the analytical mass. 
Calibration was carried out using standard solutions prepared from single element 
stock standards. Periodic checks for accuracy were performed by analysis of a 
solution of the international rock standard JB1a as an unknown - this standard was 
prepared by digesting a sample in HF/HNO3 and then HNO3. Data were plotted as 
cumulative permeation vs time.  It was necessary to pool the repeat samples and so 
replicate data were not obtained.  
 
2.9. Virucidal Activity of Receptor Phase Against HSV-1 
 Here we determined whether the receptor phases retained virucidal activity 
against HSV-1 following termination of the permeation experiment, using Vero host 
cells. The method is described in detail elsewhere (Houston, 2011; Houston et al. 
submitted not yet accepted a) and briefly involved HSV-1 incubation with the test 
material for 30 min before serial dilution and plating onto 24 well-plate of confluent 
Vero cells for a 3 day incubation, at which point the plaques were counted and results 
calculated a log-reduction.  
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2.10. Western Blot Analysis of COX-2 
 Our previous work has demonstrated that constituent phytochemicals of 
topically applied PRE penetrate ex vivo skin and result in the downregulation of 
COX-2 expression (Houston et al. submitted not yet accepted b) - here we tested the 
hypothesis that these phytochemicals as permeants in the receptor phase retain this 
previously observed antiinflammatory activity. In a departure from the method 
outlined in section 2.5, full thickness, ex vivo porcine membranes were used and the 
receptor phase was HBSB to prolong viability. Following termination of the 
penetration experiment (6 h) the membranes were retrieved, cleaned and homogenised 
in RIPA buffer using a probe homogeniser. The relative levels of inflammation 
marker COX-2 was carried out by Western blotting analysis using β-actin as the 
loading control, and followed a previously reported method (Houston 2011; Abu 
Samah and Heard, 2014) 
 
2.11. Data Processing 
 Statistical tests were performed using Instat 3 for Macintosh. A one way 
analysis of variance test was applied with a confidence interval of 95%, and a p value 
of <0.05 was considered significant.  If values were found to be of significance a 
Turkey-Kramer multiple comparison test was applied. 
 
3. Results and discussion 
3.1. Permeation of Punicalagin and Zinc (II) across Epidermal Membranes  
 Figure 2 depicts the permeation profiles of punicalagin across heat-separated 
epidermis from hydrogels H1 and H2; a blank gel was run as a control. Results show 
that the permeation of punicalagin from H2 was higher than H1 due to the higher 
concentration and therefore higher chemical potential within this gel. Thus a greater 
release and permeation of punicalagin from the hydrogel matrix would be expected. 
Permeation of punicalagin from H2 was detectable within 0.5 h (1 nM cm-2). 
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However, Table 1 shows that punicalagin permeation after 6h was approximately 4x 
more from H2 compared to H1 (4.2 ± 0.15 vs 0.96 ± 0.36 nM cm-2); the same 
difference was maintained after 12h (5.4 ± 0.35 vs 1.4 ± 0.36 nM cm-2). This was 
surprising given the 2.5x difference in PRE loading between the two hydrogels. 
 Figure 3 shows the permeation of zinc across the epidermal membranes from 
hydrogels H1 and H2 and blank. It can be seen that zinc was detectable in the receptor 
phase after application of the control blank gel and was due to a leaching of zinc 
which is naturally found in the skin. Table 1 shows that zinc permeation after 6h was 
approximately 2.3x more from H2 compared to H1 (520 vs 220 ± nM cm-2); the same 
difference was maintained after 12h (630 vs 260 nM cm-2). This differential was in 
line with 2.5x difference in ZnSO4 loading between the two hydrogels.  
 Together, Figures 2 and 3 demonstrate that both punicalagin and zinc 
permeated the epidermis following the topical application of hydrogels H1 and H2. 
This is despite the fact that punicalagin is a large molecule with a MW of 1084.7, 
whereas the optimum for skin permeation is around 350, and the purported general 
impermeability of skin to small polar molecules such as Zn2+. In the formulations zinc 
was in present excess over punicalagin and this was reflected in the permeation data 
show there was a molar excess of permeated zinc/punicalagin which was greater for 
H1 (approx. x207) than H2 (approx. x120). 
 
3.2. Localisation of Punicalagin in Heat Separated Epidermis Basal Layer Region 
 Epidermal membranes were recovered at 24 h and subjected to reverse tape 
stripping, with three strips taken on each occasion. Figure 4 shows that from both 
hydrogels applied, punicalagin localised at significantly higher concentration within 
the lowest strip, i.e. the basal layer (p<0.05). The second and third tape strip revealed 
a significantly lower level of punicalagin delivery by both gels, towards the skin 
surface. The fact that localisation from hydrogels H1 and H2 were the same indicates 
in both cases the attainment of membrane saturation ie no capacity to bind further 
molecules. The effect on binding of the probable presence of other constituents within 
PRE is unknown. Overall, these data confirm that punicalagin was successfully 
delivered to the skin site where HSV-1 and -2 vesicular clusters occur. 
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3.3. Virucidal Activity of Franz Diffusion Cell Receptor Phases Against HSV-1 
 The receptor phases were recovered after 24h and used to challenge HSV-1 
infected host cells, and the HSV-1 virucidal data are shown in Figure 5. When the 
skin was dosed with blank hydrogel the receptor phase from the blank hydrogel 
showed negligible log reduction of viral load. However, the receptor phase from 
hydrogel H2 resulted in a significant 2.57 ± 0.36 log reduction of HSV-1 plaque-
forming units (pfus). This demonstrates the successful delivery of both punicalagin 
and Zn II across the heat separated epidermis in the concentration ranges of both 
compounds that provide virucidal activity (Houston et al. submitted not yet accepted 
a) 
3.4. Anti-inflammatory Activity 
 To verify that the permeation of punicalagin from hydrogel H2 retained anti-
inflammatory activity as found previously (Houston et al. submitted not yet accepted 
b), the relative levels of COX-2 were determined by Western blotting analysis of ex 
vivo skin. Hydrogel H2 and blank control were applied to ex vivo full thickness 
porcine skin within a Franz diffusion cell for 6 h. After this time SDS-PAGE and 
Western blotting were carried out for COX-2, as an inflammatory marker, using β-
Actin as ubiquitous protein loading control. Figure 6 shows the bands produced by 
Western blot analysis for COX-2 expression at ~ 72 kDa and the protein loading 
control of β-actin at ~42 kDa. Densitometric analysis of the bands for COX-2 were 
normalised using β-actin, levels of COX-2 expression in the control were arbitrarily 
assigned a value of 100%. The application of hydrogel H2 caused the statistically 
significant reduction of COX-2 expression by 67.69 ± 3.93% (p<0.01), and 
demonstrates the permeated compounds were able to modulate the arachidonic acid 
inflammation pathway by downregulating COX-2 production.  The reduction of 
COX-2 following the application of the hydrogel H2 was statistically the same as that 
observed when (1 mg mL-1) PRE was dosed – data not shown. 
3.5. Permeation of Punicalagin and Zinc II Across Buccal Membranes  
 Buccal membrane was used as a model for the presentation of HSV-1 lesions 
within mucous membranes of the buccal cavity. Figure 7 shows the permeation of 
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punicalagin from hydrogel H2 across buccal membrane compared to that across 
epidermal and vaginal membranes. Permeation of punicalagin was detectable within 
0.5 h (1 nM cm-2). After 6h the permeation of punicalagin across buccal membrane 
was approximately half that across epidermal membrane (1.95 ± 0.5 vs 4.2 ± 0.15 nM 
cm-2 respectively). After 12 h, the differential was the same (2.6 ± 0.7 vs 5.4 ± 0.35 
nM cm-2 respectively). 
Pooled skin extracts analysed by ICPMS revealed that the amount of zinc 
leached from the buccal membrane after application of blank hydrogel was much 
lower concentration in comparison to epidermal membrane (Table 1). Figure 8 shows 
the permeation of zinc across the buccal membrane from H2, after blank subtraction 
in comparison with that across epidermal and vaginal membranes. Table 1 shows that 
after 6h the permeation of zinc across buccal membrane was ~ one quarter of that 
across epidermal membrane (125 vs 520 nM cm-2). After 12 h, the differential was 
similar at 3.5x (180 vs 630 nM cm-2 respectively). The permeation of profile of zinc 
over the 24 h period is similar to that through HSE - a plateau was observed after 1 h, 
maintained up to 12 h and tailing off. 
3.6. Permeation of Punicalagin and Zinc II Across Vaginal Membranes 
 The permeation of punicalagin from hydrogel H2 across the vaginal 
membrane, along with that across epidermal and buccal membranes, is illustrated in 
Figure 7. Permeation of punicalagin was detectable within 0.5 h (0.7 nM cm-2). The 
permeation of punicalagin across vaginal membrane was lower than across buccal 
membrane, although not statistically significant at the 95% level. Table 1 shows that 
at 6 h the amounts permeated were 1.45 ± 0.25 vs 1.95 ± 0.5 nM cm-2 respectively 
(p>0.05); at 12 h the amounts permeated were 1.7 ± 0.3 vs 2.6 ± 0.7 nM cm-2 
respectively (p>0.05).  However, as with buccal membranes the permeation of 
punicalagin across vaginal membranes was statistically lower than across epidermal 
membranes 
 The permeation of zinc across the vaginal mucosal membrane from H2 after 
blank subtraction is shown in Figure 8.  The leaching of zinc from the vaginal 
membranes after application blank hydrogel was not significantly different (p>0.05) 
to that leached from the buccal membrane (not shown), but was a lot less than that 
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from the epidermal membrane. However, the permeation profile in Figure 8 reveals 
that zinc permeated to a much greater extent compared to both epidermal and buccal 
membranes. Although zinc salts have been reported to inactivate HSV-1 isolates 
(Arens and Travis, 2000) zinc salt solutions have also been reported to cause 
sloughing of sheets of vaginal epithelial cells (Bourne et al. 2005). Although this 
provides for increased permeation of biocide, it also has the potential to cause damage 
to the vaginal mucosal membrane that might increase susceptibility to secondary 
infections at a later time. 
3.7. Comparison of Reverse Tape Stripping Epidermal, Buccal and Vaginal 
Membranes after 24 h Application of H2 
 Figure 9 shows a comparison of the punicalagin recovered by reverse tape 
stripping of the epidermal, buccal and vaginal membranes. The values, 0.47 ± 0.016, 
0.45 ± 0.052 and 0.51 ± 0.048 nM cm-2 respectively, were in close agreement and 
statistically the same (p<0.05). The results indicate that punicalagin is being delivered 
similarly through all three membranes to the target site where vesicular clusters occur. 
4. Conclusions 
This work has demonstrated that a simple hydrogel based upon 2.5% HPMC, 
1.25 mg mL-1 PRE and 0.25 M ZnSO4 in pH4.5 phthalate buffer was able to topically 
deliver the major bioactive compound within PRE and Zn (II) across membranes and 
to the site specific regions of Herpes simplex vesicular clusters. This is despite the 
relatively large MW of punicalagin and small charged nature of zinc ions which 
would conventionally suggest their relatively low permeability. In doing so, the 
potentiated virucidal and anti-inflammatory activities observed previously were 
maintained. In summary, a novel therapeutic system for the topical treatment of HSV-
1 and HSV-2 lesions is proposed based on the pomegranate in combination with Zn 
(II). 
 
Acknowledgements 
  16   
This work was financially supported by Welsh Assembly Government grant 
RFSSA07-03-013. 
 
 
  17   
REFERENCES 
Abu Samah, N.H., Heard, C.M., 2014. The effects of topically applied polyNIPAM-
based nanogels and their monomers on skin cyclooxygenase, ex vivo. Nanotoxicology 
8, 100-106. 
 
Al-Zoreky, N.S., 2009. Antimicrobial activity of pomegranate (Punica granatum L.) 
fruit peels. International Journal of Food Microbiology 134, 244-48. 
 
Arens, M., Travis, S., 2000. Zinc salts inactivate clinical isolates of herpes simplex 
virus in vitro. J. Clin. Microbiol. 38, 1758-1762. 
 
Bourne, N., Stegall, R., Montano, R., Meador, M.,, Stanberry, L.R., Milligan, G.N., 
2005. Efficacy and toxicity of zinc salts as candidate topical microbicides against 
vaginal herpes simplex virus type 2 infection. Antimicrobial Agents and 
Chemotherapy Antimicrob. 49, 1181-1183. 
 
Colombo, E., Sangiovanni, E., Dell'Agli, M., 2013. A review on the anti-
inflammatory activity of pomegranate in the gastrointestinal tract. Evidence-Based 
Complementary and Alternative Medicine, Article ID 247145. 
 
  18   
Dodov, M.G., Goracinova, K., Simonoska, M., Trajkovic-Jolevska, S., Ribarska, J.T., 
Mitevska, M.D., 2005. Formulation and evaluation of diazepam hydrogel for rectal 
administration. Acta Pharm. 55, 251-261. 
 
Haidari, M., Ali, M., Casscells, S.W., Madjid, M., 2009. Pomegranate (Punica 
granatum) purified polyphenol extract inhibits influenza virus and has a synergistic 
effect with oseltamivir. Phytomedicine 16, 1127–1136. 
 
Houston, D.M.J., 2011. Towards a nanomedicine-based broadspectrum topical 
virucidal therapeutic system. PhD thesis, Cardiff University. 
 
Houston, D.M.J., Bugert, J.J., Denyer, S.P., Heard, C.M. Submitted not yet accepted, 
a. Potentiated virucidal and anti-viral activity of pomegranate rind extract and zinc II 
ions against Herpes simplex virus and aciclor-resistant Herpes simplex virus.  
 
Houston, D.M.J., Bugert, J.J., Denyer, S.P., Heard, C.M. Submitted not yet accepted, 
b. Probing the ex vivo anti-inflammatory properties and cytotoxicity of topically 
applied pomegranate rind extract, total pomegranate tannins and zinc sulphate.  
 
Howell, A.B., D'Souza, D.H., 2013. The pomegranate: effects on bacteria and viruses 
that influence human health. Evidence-Based Complementary and Alternative 
Medicine. Article ID 606212. 
 
Jurenka, J., 2008. Therapeutic applications of pomegranate (Punica granatum L.): A 
Review. Alternative Medicine Review 13, 128-144. 
  19   
 
Kligman, A.M., Christophers, E., 1963. Preparation of isolated sheets of human 
stratum corneum. Archives of Dermatology 88, 702-705. 
 
Konowalchuk, J., Speirs, J.I., 1976. Antiviral activity of fruit extracts. Journal of Food 
Science 41, 1013–1017. 
 
Li, D., Baert, L., Xia, M., Zhong, W., Jiang, X., Uyttendaele, M., 2012. Effects of a 
variety of food extracts and juices on the specific binding ability of norovirus GII. 4 P 
particles. Journal of Food Protection 75, 1350–1354. 
 
Li, G., Brockman, J.D., Lin, S.W., Abnet, C.C., Schell, L.A., Robertson, J.D., 2012. 
Measurement of the trace elements Cu, Zn, Fe, and Mg and the ultratrace elements 
Cd, Co, Mn, and Pb in limited quantity human plasma and serum samples by 
inductively coupled plasma-mass spectrometry. American Journal of Analytical 
Chemistry 3, 646-650. 
 
Mustafa, C., Yasar, H., Gokhan, D., 2009. Classification of eight pomegranate juices 
based on antioxidant capacity measured by four methods. Food Chemistry 112, 721-
726. 
 
Negi, P.S., Jayaprakasha, G.K., 2003. Antioxidant and antibacterial activities of 
Punica granatum peel extracts. Food Microbiology and Safety 68, 1136-1553. 
 
  20   
Neurath, R., Strick, N., Li, Y.Y., Debnath, A.K., 2005. Punica granatum 
(pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical 
microbicide. In Natural Products and Molecular Therapy, G. J. Kotwal and D. K. 
Lahiri, Eds., 1056: 311–327, New York Academy of Sciences. 
 
Pringle, C.R., 2016. Herpes Simplex Virus Infections. 
https://www.merckmanuals.com/home/infections/viral-infections/herpes-simplex-
virus-infections 
 
Salameh, S., Sheth, U., Shukla, D., 2012. Early events in herpes simplex virus 
lifecycle with implications for an infection of lifetime. Open Virol J. 6, 1–6. 
 
Seeram, N.P., Adams, L.S., Henning, S.M., Niu, Y., Zhang, Y., Nair, M.G., Heber, 
D., 2005. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, 
ellagic acid and a total pomegranate tannin extract are enhanced in combination with 
other polyphenols as found in pomegranate juice. Nutritional Biochemistry 16, 360-
367 
 
Stewart, G.S.A.B., Jassim, S.A., Denyer, S.P., 1998. The specific and sensitive 
detection of bacterial pathogens within 4 h using bacteriophage amplification. 
Applied Microbiology 84, 777-783. 
 
Su, X., Sangster, M.Y., D'Souza, D.H., 2010. In vitro effects of pomegranate juice 
and pomegranate polyphenols on foodborne viral surrogates. Foodborne Pathogens 
and Disease 7, 1473–1479. 
  21   
 
Williams, A.C., 2003. Transdermal and Topical Drug Delivery, from Theory to 
Clinical Practice. Pharmaceutical Press, London. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  22   
Figure legends 
 
 
 
Figure 1 HPLC chromatogram of punicalagin showing peaks for  and  anomers in 
1:2 ratio and resulting calibration curves. 
 
 
Figure 2 Cumulative permeation of punicalagin across epidermis after application of 1 
mL hydrogels H1, H2 and blank control (mean ± SD, n= 4). 
 
Figure 3 Cumulative permeation of zinc across epidermis after of 1 mL hydrogels H1, 
H2 and blank control (mean ± SD, n= 4). 
 
Figure 4 Reverse tape stripping: punicalagin recovered after 24h by reverse tape 
stripping three times epidermal membranes (1 being lowest) dosed with formulation, 
for each pair of bars: left = H1 and right = H2 (mean ± SD, n= 4). 
 
Figure 5 Virucidal log reduction of HSV-1 after the incubation with receptor phase 
following 24 h application of H1 and H2 to epidermis, blank was negligible (mean ± 
SD, n= 4). 
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Figure 6 Modulation of COX-2 protein expression following dosing of ex vivo skin 
with receptor phase following 6h application of H2 and phthalate buffer as a control 
to ex vivo skin. Protein was extracted and 30 µg was loaded and separated through 
SDS-PAGE. The histogram represents numerical data of COX-2 normalised using β-
actin. Levels in the control were arbitrarily assigned a value of 100% (mean ± SD, n= 
4). 
 
Figure 7 Permeation profile of punicalagin from H2 and blank across the epidermal, 
buccal and vaginal membranes (mean ± SD, n= 4). 
 
Figure 8 Permeation profiles for zinc across epidermal, buccal and vaginal 
membranes after application of H2 (singlicate determination). 
 
Figure 9 Reverse tape stripping: comparison of punicalagin recovered from lowest 
reverse tape strip after 24 h application of hydrogel H2 to epidermal, buccal and 
vaginal membranes (mean ± SD, n= 4). 
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Table 1: Cumulative permeation of punicalagin (mean ± SD, n= 4) and zinc (n=1) 
from 2.5% HPMC hydrogels across epidermal, buccal and vaginal membranes. H2: 
PRE 1.25 mg mL-1, ZnSO4 0.25 M; H1 PRE 0.5 mg mL-1, ZnSO4 0.1 M; blank PRE 
0, ZnSO4 0. 
Membrane Hydrogel Punicalagin 6h 
nM cm-2 
Zn 6h 
nM cm-2 
Punicalagin 12h 
nM cm-2 
Zn 12h 
nM cm-2 
 
Epidermal 
H2 4.2 ± 0.15 520 5.4 ± 0.35 630 
H1 0.96 ± 0.36 220 1.4 ± 0.36 260 
blank - 85 - 90 
 
Buccal 
H2 1.95 ± 0.5 125 2.6 ± 0.7 180 
blank - 10 - 13 
 
Vaginal 
H2 1.45 ± 0.25 22 x 103 1.7 ± 0.3 29 x 103 
blank - 0.5 - 0.5 
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Figure 1 
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Figure 4  
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Figure 5  
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Figure 7  
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Figure 9 
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